Status:
COMPLETED
Vitamin D in Egyptian Children With Atopic Dermatitis
Lead Sponsor:
National Hepatology & Tropical Medicine Research Institute
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
5-16 years
Phase:
PHASE3
Brief Summary
There is an emergent evidence demonstrating the role of Vitamin D deficiency in eczema. Vitamin D supplementation with standard treatment yielded positive clinical outcomes for children and adolescent...
Eligibility Criteria
Inclusion
- diagnosis of severe AD according to Hanifin and Rajka criteria and the Eczema Area and Severity Index (EASI) score
Exclusion
- serious skin disorder other than AD.
- taking systemic corticosteroids or anti-inflammatory medications, prior vitamin D supplementation
- receiving oral or topical antibiotics or topical calcineurin inhibitors for at least one week prior to enrollment
- known gut absorption problem, presence of active skin infection at baseline any known hepatic and/or renal disease.
Key Trial Info
Start Date :
June 6 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 4 2019
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT04468711
Start Date
June 6 2018
End Date
June 4 2019
Last Update
July 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NHTRMI
Cairo, Egypt